Asuragen is an in vitro molecular
diagnostics company with worldwide distribution of its products focused on cancer and genetic diseases.
Qvella is a molecular
diagnostics company with the goal of dramatically reducing time to actionable results.
Theranos is
a diagnostics company with fast finger - prick blood testing technology that aims to upend the traditional health care establishments by making it easier, less expensive and less uncomfortable to get tested for various conditions.
ArcticDx is a molecular
diagnostic company with a focus on commercializing genetic discoveries.
Not exact matches
And the
company hopes the system can drastically improve the «
diagnostic journeys» that those
with rare diseases typically face: Such patients, on average, are seen by seven doctors before the correct diagnosis is made.
A vision
company with vision goes beyond «buy - one, give - one,» to create a self - sustaining
diagnostic and education program.
The
company, meanwhile, is churning out new tools that can perform more kinds of operations, expanding feverishly into Asia, and experimenting well outside its comfort zone
with cancer
diagnostics.
«The goal is to analyze, utilize and share the data generated
with the objective of enhancing
diagnostic abilities and improving patient outcomes,» the
company said in a statement.
Important factors that could cause our actual results and financial condition to differ materially from those indicated in the forward - looking statements include, among others, the following: our ability to successfully and profitably market our products and services; the acceptance of our products and services by patients and healthcare providers; our ability to meet demand for our products and services; the willingness of health insurance
companies and other payers to cover Cologuard and adequately reimburse us for our performance of the Cologuard test; the amount and nature of competition from other cancer screening and
diagnostic products and services; the effects of the adoption, modification or repeal of any healthcare reform law, rule, order, interpretation or policy; the effects of changes in pricing, coverage and reimbursement for our products and services, including without limitation as a result of the Protecting Access to Medicare Act of 2014; recommendations, guidelines and quality metrics issued by various organizations such as the U.S. Preventive Services Task Force, the American Cancer Society, and the National Committee for Quality Assurance regarding cancer screening or our products and services; our ability to successfully develop new products and services; our success establishing and maintaining collaborative, licensing and supplier arrangements; our ability to maintain regulatory approvals and comply
with applicable regulations; and the other risks and uncertainties described in the Risk Factors and in Management's Discussion and Analysis of Financial Condition and Results of Operations sections of our most recently filed Annual Report on Form 10 - K and our subsequently filed Quarterly Reports on Form 10 - Q.
Private equity firm Carlyle Group is exploring a sale or initial public offering of Ortho - Clinical
Diagnostics Inc, a U.S.
diagnostics company that could be valued at more than $ 7 billion, including debt, people familiar
with the matter said.
Andrew's primary responsibility at RA Capital is to evaluate public and private investments in
companies developing drugs, medical devices,
diagnostics, and research tools,
with a focus on new
company formation.
BioGeneration Ventures (BGV) is a venture capital
company,
with a focus on early stage European biotech, medtech, and
diagnostics companies.
Ysios Capital is a leading Spanish venture capital firm that provides private equity financing to early - and mid-stage human healthcare and life science
companies with a special focus on pharmaceuticals,
diagnostics and medical devices.
Adavium Medical is the largest Brazilian medical equipment and
diagnostics company,
with Brazil being the third largest private healthcare market in the...
In March, the
company merged
with a blood
diagnostics company in China.
The
diagnostic imaging specialist said that net income rose by more than 25 % during the quarter on a modest 4 % rise in revenue,
with the
company's Definity and TechneLite devices providing much of the growth in sales.
Drug developer Loxo Oncology said on Tuesday it is partnering
with genetic testing
company Illumina Inc on a
diagnostic tool that will work
with Loxo's larotrectinib and another one of its experimental cancer drugs, across tumor types.
April 10 Drug developer Loxo Oncology said on Tuesday it is partnering
with genetic testing
company Illumina Inc on a
diagnostic tool that will work
with Loxo's larotrectinib and another one of its experimental cancer drugs, across tumor types.
Loxo Oncology is partnering
with genetic testing
company Illumina Inc to use Illumina's
diagnostic tool alongside larotrectinib, the drug developer's potential blockbuster drug, the
companies said on Tuesday.
About ChipCare ChipCare is a Toronto - based
company producing life - saving
diagnostics for infectious and non-communicable diseases in remote health settings
with a mobile, simple - to - use & lab quality blood - testing platform.
April 10 Loxo Oncology is partnering
with genetic testing
company Illumina Inc to use Illumina's
diagnostic tool alongside larotrectinib, the drug developer's potential blockbuster drug, the
companies said on Tuesday.
Brian Peifer, broker of record for Royal LePage Peifer Realty in Chatham, Ont., along
with office manager Deb Roberts, donated more than $ 4,000 from their
company to the Chatham - Kent Health Alliance
Diagnostic Imaging Machine Campaign.
Vancouver, B.C. - headquartered CVR Medical Corp., a medical
diagnostics technology
company, has signed an official letter of intent
with Guangzhou LangRun Equity Investment Management Co. Ltd., a professional equity investment fund management platform
company headquartered in Guangzhou, China.
Companies with a location in the KC Animal Health Corridor — which is a trademarked and Federally designated term — represent 56 percent of total worldwide animal health,
diagnostics and pet food sales, making Kansas City the capital of the corridor.
In 1994, Bain invested $ 27 million as part of a deal
with other firms to acquire Dade International, a medical -
diagnostics - equipment firm, from its parent
company, Baxter International.
In Maitland, the proposed acquisition would result in Sonic being one of two private radiology
companies that supply general
diagnostic imaging services,
with Sonic operating four out of five radiology practices.
Head Case: Founded by concerned parents of competitive kids, Head Case is a sports technology
company with the mission to protect athletes from the cumulative risk of undetected concussions.Head Case are the creators behind Head Case, an affordable three - part head health management systemthat that measures and records head impacts in G - force, provides alerts on impacts of concern, offers
diagnostic tools to detect signs and symptoms of potential concussions, and recommends the best treatment facilities in an athlete's current location.
In response to this need,
companies such as the Head Case
Company have developed a reliable helmet shock sensor designed to measure and record impact, send out alerts, and provides information and
diagnostic tools to help
with concussion detection.
The National University of Singapore (NUS) recently concluded a deal
with Singapore - based life science upstart Asia Pacific Genomics (AP Genomics), giving the
company exclusive rights to exploit its proprietary type - specific dengue fever
diagnostic primers.
The
company wanted to use it as a
diagnostic marker for disease: If synthetic versions of antibodies could be tagged
with aequorin in the lab, then whenever they matched up
with an antigen (or surface protein) of a specific pathogen in blood or tissue, the sample would glow.
Tests have been running smoothly in the lab, she notes,
with some
diagnostics companies already interested in the technology.
Medical
diagnostics is getting better all the time, says Robert Langer, an engineer at MIT who has set up a
company that uses ultrasound to let people
with diabetes collect data on their glucose levels.
There are already some
companies dedicated to bringing ribozymes from the laboratory to the commercial world,
with potential applications as sensitive sensors of biowarfare germs or as medical
diagnostic tests.
Christian Happi at Redeemer's University in Ede, Nigeria, and the Irrua Specialist Teaching Hospital is developing a rapid
diagnostic test
with colleagues at Tulane University in New Orleans, Louisiana; the Broad Institute in Cambridge, Massachusetts; and Zalgen, a
company in Germantown, Maryland.
Building up from tabletop devices, by last year the
company was employing 150 people and was working
with C - 2, a 23 - meter - long tube ringed by magnets and bristling
with control devices,
diagnostic instruments, and particle beam generators.
The Duke team has previously explored blood tests to examine a patient's RNA for gene signatures to distinguish bacterial and viral infections in the upper respiratory tract and is working
with a private
company to develop potential
diagnostics.
The research scientist just 4 years into her first industry job
with a
company that makes
diagnostic tests and reagents, who finds as she reenters the job market that she is not a strong candidate for bench - science jobs in the biotech industry because she has been labeled a «
diagnostics industry» employee.
In order to most rapidly realize the value of genetics for human health, deCODE is currently partnering
with life sciences
companies to accelerate their target discovery, validation, and prioritization efforts, yielding improved patient stratification for clinical trials and essential companion
diagnostics.
ISOMA is in early stage discussions
with potential strategic partners to develop ISOMA Diagnostics» molecular test into a companion
diagnostic that can help
companies and doctors steer patients towards the right treatment choices.
With more than 1,200 international actors from 35 + countries, such as big pharma, emerging and small biotech,
diagnostics companies, pre-seed / seed / Series A investors, as well as professionals from tech transfer, academia and research institutions, BioFIT is the leading partnering event in Europe for technology transfer, academia - industry collaborations and early - stage innovations in the field of Life Sciences.
HLI has signed an agreement
with Metabolon Inc., a
diagnostic products and services
company offering the biochemical profiling platform, to capture this information from each of the genomic samples that HLI is collecting.
Curetis N.V. (the «
Company» and, together
with Curetis USA Inc. and Curetis GmbH, «Curetis»), a developer of next - level molecular
diagnostic solutions, today announced the successful completion of clinical performance evaluation and CE - IVD marking of its novel Unyvero Application Cartridge, UTI, for the diagnosis of severe urinary tract infections.
Potential risks and uncertainties include, but are not limited to, the risks: a) deCODE's previously discovered at - risk variants may not be sufficiently informative to have
diagnostic value; b) Illumina's BeadLab infrastructure may not support sufficiently the high sample throughput envisioned by the parties; c) Illumina may not manufacture HumanHap BeadChips in adequate quantity or quality; d) the
companies may not see an increased customer base as a result of the collaboration, as well as other risks and uncertainties detailed from time to time in deCODE's or Illumina's filings
with the Securities and Exchange Commission.
In 1994 he founded Definiens, a
company dedicated to developing advanced processing tools for maximizing the information that can be gathered from images,
with particular use for applications in medical
diagnostics.
Mike Koeris, a co-founder of Sample6 Technologies along
with Timothy Lu, spoke
with us about his
company's work developing a
diagnostic for detecting bacteria like listeria in food.
Alex joined Illumina when the
company acquired Helixis, a molecular
diagnostic company he co-founded
with Nobel Laureate David Baltimore.
Esko is collaborating
with Zacharon Pharmaceuticals, a San Diego - based biotechnology
company, to develop a commercial
diagnostic assay for differentiating forms of MPS from urine and blood samples, a screening test for newborns and a tool for measuring the biochemical response of MPS patients to existing and novel therapies.
In addition, the
company collaborates
with biopharmaceutical
companies in the development of companion
diagnostic tests and technologies for various cancer therapies, helping to realize the promise of precision oncology.
SAN DIEGO, March 28, 2017 (GLOBE NEWSWIRE)-- Invivoscribe ® Technologies Inc., a global
company with decades of experience providing internationally standardized clonality and biomarker testing solutions for the fields of oncology, personalized molecular
diagnostics ®, and personalized molecular medicine ®, reports that its next - generation sequencing (NGS) LymphoTrack ® Assay kits are being used by its LabPMM ® clinical laboratories, pharmaceutical partners, and cancer centers to identify and monitor chimeric antigen receptor T - cells (CAR - T) and engineered T - cell receptors in peripheral blood of subjects in support of immuno - therapeutic drug development and treatment regimen development for both hematologic and solid tumors.
The
company Biomeme developed a mobile genetic
diagnostic platform that features hardware used
with an iPhone, software, DNA test kits and an app to provide results on the field in under an hour.